On 27 October 2017, the Agency requested the following additional information from the applicant [Communication R4BP: UBP-C-1276876-07-00/F.]:
a modification concerning the indication of the change in the ‘Name of the authorisation holder’ in the supporting document of the application;
a modification concerning the indication of a new formulator of the biocidal product in the supporting document of the application;
proof that the biocidal product composition and the formulating process remained unchanged;
a modification concerning the indication of the removal of a certain meta or use in the supporting document of the application.
That information was provided by the applicant on 16 November 2017. The application was validated on 11 December 2017.